J&J faces South African com­pe­ti­tion probe over high tu­ber­cu­lo­sis drug prices

South Africa’s Com­pe­ti­tion Com­mis­sion is set to probe John­son & John­son amid claims that the Big Phar­ma is charg­ing the na­tion more than dou­ble than the rest of the world for its tu­ber­cu­lo­sis  drug be­daquiline.

In a brief­ing host­ed by the Health Jus­tice Ini­tia­tive (HJI) and oth­er health ad­vo­ca­cy groups, HJI founder Fa­ti­ma Has­san said the in­ves­ti­ga­tion would look at whether J&J’s ex­clu­sion of patents vi­o­lat­ed South African com­pe­ti­tion law.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER